Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease

Fig. 1

CSF TMAO levels are elevated in individuals with AD dementia and MCI compared to cognitively-unimpaired individuals, after controlling for age, sex, and APOE ε4 genotype. Data presented as violin plots (displaying scaled distribution of data for each group) with inset Tukey boxplots showing median, interquartile range (IQR), and 1.5 × IQR. AD Alzheimer’s disease, CSF cerebrospinal fluid, MCI mild cognitive impairment, TMAO trimethylamine N-oxide

Back to article page